"Integrase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds which inhibit or antagonize biosynthesis or actions of integrase.
| Descriptor ID |
D019429
|
| MeSH Number(s) |
D27.505.519.389.375
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Integrase Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Integrase Inhibitors".
This graph shows the total number of publications written about "Integrase Inhibitors" by people in this website by year, and whether "Integrase Inhibitors" was a major or minor topic of these publications.
Below are the most recent publications written about "Integrase Inhibitors" by people in Profiles.
-
Effects of Initiating Raltegravir-Based Versus Efavirenz-Based Antiretroviral Regimens During Pregnancy on Weight Changes and Perinatal Outcomes: NICHD P1081. J Acquir Immune Defic Syndr. 2022 12 01; 91(4):403-409.
-
Susceptibility of Human Endogenous Retrovirus Type K to Reverse Transcriptase Inhibitors. J Virol. 2017 12 01; 91(23).
-
A critical subset model provides a conceptual basis for the high antiviral activity of major HIV drugs. Sci Transl Med. 2011 Jul 13; 3(91):91ra63.
-
Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Clin Infect Dis. 2008 Jul 15; 47(2):266-85.
-
Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs. Nat Med. 2008 Jul; 14(7):762-6.
-
Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle. Proc Natl Acad Sci U S A. 2008 Mar 25; 105(12):4832-7.
-
Clinical implications of resistance to antiretrovirals: new resistance technologies and interpretations. Antivir Ther. 2008; 13(2):319-34.